GGrantIndex
Sort

85,873 grants matching alzheimers

Maladaptive antiviral pathways in Alzheimer's disease

$834,101
Li Gan · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AG

Post-stroke Cognitive Impairment and Dementia

$834,094
Ying Xian · Ut Southwestern Medical Center · R01 · FY2024 · AG

Regulation of tau expression in Alzheimer disease and aging

$834,068
John Fonda Crary · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · AG

Regulation mechanism and functional genomics of LINE1 RNA in TDP-43 linked neurodegeneration

$834,011
Shuying Sun · Johns Hopkins University · R01 · FY2023 · AG

Neural substrates of diffusion imaging in cognitively aging rhesus monkeys

$833,908
Marek Kubicki · Brigham And Women'S Hospital · R01 · FY2021 · AG

Mechanisms of sleep deficiency and effects on brain injury and neurocognitive functions among older blacks

$833,876
Girardin Jean-Louis · New York University School Of Medicine · R01 · FY2020 · AG

Multimodal imaging of prodromal synaptic, circuit, and network-level dysfunction in a murine model of Alzheimer's disease

$833,826
Takuya Toyonaga · Yale University · R01 · FY2025 · NS

Occupational transitions across the lifecourse and dementia risk: evaluating unemployment, occupational complexity using sequence analysis

$833,814
Anusha Murthy Vable · University Of California, San Francisco · R01 · FY2021 · AG

At-home computerized assessment of normal cognitive aging and age-related cognitive decline in older African Americans, Hispanics, and rural non-Hispanic whites

$833,800
David L Woods · Neurobehavioral Systems, Inc. · R44 · FY2025 · AG

Functional characterization of Alzheimer's disease associated genetic variants

$833,789
Yin Shen · University Of California, San Francisco · R01 · FY2020 · AG

The role of peripheral myeloid cells in Alzheimers disease

$833,701
Towfique Raj · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · AG

The role of peripheral myeloid cells in Alzheimers disease

$833,701
Towfique Raj · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · AG

Combination Therapy with Semaglutide and Anti-Amyloid Antibodies for Alzheimers Disease

$833,674
Cynthia A Lemere · Brigham And Women'S Hospital · R01 · FY2025 · AG

mHealth-Facilitated Physical Activity Toward Health (mPATH) for Cognitive Function and Sleep in Low-Income Older Adults

$833,602
Junxin Li · Johns Hopkins University · R01 · FY2023 · AG

Establishing Mechanisms of Benefit to Reinforce the Alzheimer's Care Experience AD/ADRD Roybal Center: EMBRACE

$833,460
Joseph E. Gaugler · University Of Minnesota · P30 · FY2025 · AG

The chromatin-based epigenome in development and aging

$833,436
Bruce H. Howard · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD

Sleep Aging and Risk for Alzheimer's disease-Resubmission-1

$833,431
Ricardo S Osorio · New York University School Of Medicine · R01 · FY2019 · AG

Magnetic Resonance Spectroscopy Core Facility

$833,374
Jun Shen · National Institute Of Mental Health · ZIC · FY2016 · MH

Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP Liposomes

$833,334
Wei-Chiao Huang · Pop Biotechnologies, Inc · R42 · FY2025 · AG

Systems Genetics Analysis of Alzheimer's Disease-Related Sleep Loss and the Transition to Dementia

$833,322
Catherine Cook Kaczorowski · University Of Michigan At Ann Arbor · R01 · FY2024 · AG

Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer's disease

$833,313
Antonio Convit · New York University School Of Medicine · R01 · FY2019 · AG

Functional characterization of Alzheimer's disease associated genetic variants

$833,263
Yin Shen · University Of California, San Francisco · R01 · FY2018 · AG

Digital Biomarkers for Alzheimer’s Disease

$833,195
Ihab M Hajjar · Ut Southwestern Medical Center · R01 · FY2023 · AG

Deprescribing antipsychotics in patients with Alzheimers disease and related dementias and behavioral disturbance in skilled nursing facilities

$833,178
Joshua K Lin · Brigham And Women'S Hospital · R01 · FY2025 · AG

A targeted analytical framework to optimize posthospitalization delirium pharmacotherapy in patients with Alzheimers disease and related dementias

$833,178
Joshua K Lin · Brigham And Women'S Hospital · R01 · FY2025 · AG